Alex Thompson
Stock Analyst at Stifel Nicolaus
Total Price Targets
16
Stocks Covered
12
Sectors
Healthcare
Most Recent
Mar 10, 2026
Notable Calls (Last 12 Months)
Most Bullish
Stocks Covered by Alex Thompson
| Symbol | Company | Latest Target | Current Price | Upside | # Targets | Last Updated |
|---|---|---|---|---|---|---|
| CGEM | Cullinan Therapeutics, Inc. | $28.00 | $13.48 | +107.6% | 1 | Mar 10, 2026 |
| DNTH | Dianthus Therapeutics, Inc. | $120.00 | $87.86 | +36.6% | 1 | Mar 9, 2026 |
| JBIO | Jade Biosciences, Inc. | $40.00 | $24.43 | +63.7% | 2 | Mar 6, 2026 |
| ANAB | AnaptysBio, Inc. | $85.00 | $66.67 | +27.5% | 1 | Mar 5, 2026 |
| CRNX | Crinetics Pharmaceuticals, Inc. | $75.00 | $38.93 | +92.7% | 2 | Jan 5, 2026 |
| KYMR | Kymera Therapeutics, Inc. | $114.00 | $81.54 | +39.8% | 1 | Dec 8, 2025 |
| VRDN | Viridian Therapeutics, Inc. | $48.00 | $13.41 | +257.9% | 3 | Nov 5, 2025 |
| SYRE | Spyre Therapeutics, Inc. | $71.00 | $70.20 | +1.1% | 1 | Nov 12, 2024 |
| ACRS | Aclaris Therapeutics, Inc. | $3.00 | $4.38 | -31.6% | 1 | Nov 6, 2024 |
| CLDX | Celldex Therapeutics, Inc. | $58.00 | $32.29 | +79.6% | 1 | Jun 17, 2024 |
| APGE | Apogee Therapeutics, Inc. | $95.00 | $81.23 | +17.0% | 1 | May 13, 2024 |
| PLRX | Pliant Therapeutics, Inc. | $32.00 | $1.23 | +2512.2% | 1 | May 7, 2024 |
Recent Activity
- Mar 10, 2026— Set$28.00price target onCGEM(Cullinan Therapeutics, Inc.)
- Mar 9, 2026— Set$120.00price target onDNTH(Dianthus Therapeutics, Inc.)
- Mar 6, 2026— Set$40.00price target onJBIO(Jade Biosciences, Inc.)
- Mar 5, 2026— Set$85.00price target onANAB(AnaptysBio, Inc.)
- Jan 5, 2026— Set$75.00price target onCRNX(Crinetics Pharmaceuticals, Inc.)
- Dec 8, 2025— Set$114.00price target onKYMR(Kymera Therapeutics, Inc.)
- Nov 5, 2025— Set$48.00price target onVRDN(Viridian Therapeutics, Inc.)
- May 5, 2025— Set$19.00price target onJBIO(Jade Biosciences, Inc.)
- Mar 24, 2025— Set$60.00price target onCRNX(Crinetics Pharmaceuticals, Inc.)
- Nov 12, 2024— Set$71.00price target onSYRE(Spyre Therapeutics, Inc.)
- Nov 12, 2024— Set$20.50price target onVRDN(Viridian Therapeutics, Inc.)
- Nov 6, 2024— Set$3.00price target onACRS(Aclaris Therapeutics, Inc.)
- Sep 10, 2024— Set$20.00price target onVRDN(Viridian Therapeutics, Inc.)
- Jun 17, 2024— Set$58.00price target onCLDX(Celldex Therapeutics, Inc.)
- May 13, 2024— Set$95.00price target onAPGE(Apogee Therapeutics, Inc.)
- May 7, 2024— Set$32.00price target onPLRX(Pliant Therapeutics, Inc.)
Frequently Asked Questions
Who is Alex Thompson?
Alex Thompson is a stock analyst at Stifel Nicolaus covering 12 stocks primarily in Healthcare. They have issued 16 price targets since May 7, 2024.
What stocks does Alex Thompson cover?
Alex Thompson currently covers 12 stocks, including VRDN, JBIO, CRNX, CGEM, DNTH.
What is Alex Thompson's latest price target?
Alex Thompson's most recent price target was $28.00 on CGEM (Cullinan Therapeutics, Inc.), set on Mar 10, 2026.
What is Alex Thompson's highest price target?
Alex Thompson's highest issued price target is $120.00 on DNTH, set on Mar 9, 2026.
More Analysts at Stifel Nicolaus
Coverage based on publicly published price targets. Not investment advice.